Literature DB >> 2987942

Deletion mapping of HLA and chromosome 6p genes.

F Levine, H Erlich, B Mach, R Leach, R White, D Pious.   

Abstract

We have analyzed a set of heterozygous mutants with deletions that encompass parts of HLA and surrounding regions of chromosome 6p. By a combination of Southern blotting, serologic, enzymatic, and cytogenetic analyses, we have ordered eight independent deletion break points into a sequence that divides chromosome 6p into six regions. The deletion mutants have been used in conjunction with the Southern blot technique to map HLA and other 6p gene probes into those regions. On the basis of these and other data we propose a genetic and physical map of HLA and surrounding regions of chromosome 6p. We find that for HLA probes, most of which hybridize with more than one gene, the multiple copies recognized by single probes map to single regions. Any chromosome 6p gene can now be regionally mapped by using these mutants.

Mesh:

Substances:

Year:  1985        PMID: 2987942      PMCID: PMC397863          DOI: 10.1073/pnas.82.11.3741

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Simple and rapid fluorimetric method for DNA microassay.

Authors:  J Kapuściński; B Skoczylas
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

2.  Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer.

Authors:  A K Sood; D Pereira; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

3.  Allelic polymorphism and complexity of the genes for HLA-DR beta-chains--direct analysis by DNA-DNA hybridization.

Authors:  C T Wake; E O Long; B Mach
Journal:  Nature       Date:  1982-11-25       Impact factor: 49.962

4.  Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes.

Authors:  E O Long; J Gorski; B Mach
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

5.  SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines.

Authors:  P Kavathas; R DeMars; F H Bach; S Shaw
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

6.  Family studies define a new histocompatibility locus, SB, between HLA-DR and GLO.

Authors:  S Shaw; P Kavathas; M S Pollack; D Charmot; C Mawas
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

7.  Gene dosage and gene expression in the HLA region: evidence from deletion variants.

Authors:  P Gladstone; L Fueresz; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

8.  Report of the committee on the genetic constitution of chromosome 6. Oslo Conference (1981): Sixth International Workshop on Human Gene Mapping.

Authors:  L R Weitkamp; L U Lamm
Journal:  Cytogenet Cell Genet       Date:  1982

9.  [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].

Authors:  H Kratzin; C Y Yang; H Götz; E Pauly; S Kölbel; G Egert; F P Thinnes; P Wernet; P Altevogt; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1981-12

10.  Polymorphism and complexity of the human DC and murine I-A alpha chain genes.

Authors:  C Auffray; A Ben-Nun; M Roux-Dosseto; R N Germain; J G Seidman; J L Strominger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  14 in total

1.  Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Authors:  E Mellins; B Arp; D Singh; B Carreno; L Smith; A H Johnson; D Pious
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

2.  Analysis of HLA-DMB mutants and -DMB genomic structure.

Authors:  J Shaman; E von Scheven; P Morris; M D Chang; E Mellins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis.

Authors:  P I Lobo; M Y Chang; E Mellins
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  Modulation of major histocompatibility class II protein expression by varicella-zoster virus.

Authors:  A Abendroth; B Slobedman; E Lee; E Mellins; M Wallace; A M Arvin
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Authors:  T Spies; C C Morton; S A Nedospasov; W Fiers; D Pious; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 6.  The molecular genetics of human chromosome 6.

Authors:  V Cunliffe; J Trowsdale
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

7.  Transcription analysis, physical mapping, and molecular characterization of a nonclassical human leukocyte antigen class I gene.

Authors:  M J Chorney; I Sawada; G A Gillespie; R Srivastava; J Pan; S M Weissman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

8.  Human immunodeficiency virus gp120 binding C'C" ridge of CD4 domain 1 is also involved in interaction with class II major histocompatibility complex molecules.

Authors:  U Moebius; L K Clayton; S Abraham; A Diener; J J Yunis; S C Harrison; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma.

Authors:  V Jung; A Rashidbaigi; C Jones; J A Tischfield; T B Shows; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

10.  Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors.

Authors:  J Soh; R J Donnelly; T M Mariano; J R Cook; B Schwartz; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.